शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
VIYASHNSEViyash Scientific Limited· Pharmaceuticals & BiotechnologyHighNeutral
Announced Wed, 19 Nov, 2025 · 14:50 IST

Written order of NCLT, Hyderabad Bench.Arrangement

VIYASH · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+1.7%Reaction day
₹247.51
prior close
₹254.76
announcement price
In-mkt
timing
Nifty Microcap 250market · index membership as recorded later (tracked since Jun 2026)-0.2%+1.9% vs market
Pharmaceuticals peers, median of 156sector-0.5%+2.2% vs sector

On the reaction day the stock moved 1.9 pts more than Nifty Microcap 250 and 2.2 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-0.3
10m
-0.8
15m
-1.0
30m
-0.7
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+1.7-0.2+1.9-0.5+2.2
Next day
-3.4-0.5-2.9-0.5-2.9
2d
-3.6-2.0-1.6-1.2-2.4
3d
-10.3-2.6-7.7-2.2-8.1
4d
-10.4-2.5-7.9-2.0-8.4
5d
-10.7-1.2-9.5-1.3-9.4
1w
-9.2-1.7-7.5-1.6-7.7
15d
-19.2-5.6-13.7-3.4-15.8
1m
-15.0-5.0-10.0-4.0-11.0
2m
-16.9-9.0-7.9-6.7-10.2
3m
-12.8-7.7-5.1-9.6-3.3
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 156Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Viyash Scientific Limited has announced that the National Company Law Tribunal (NCLT), Hyderabad Bench has pronounced a written order relating to an arrangement. The exact nature of the arrangement (such as a merger, demerger, or restructuring scheme under Sections 230-232 of the Companies Act) is not specified in the brief filing. This typically follows a hearing where the company sought NCLT's approval for a corporate restructuring plan. Shareholders and creditors would have been involved in the approval process before the tribunal's order. Further details on the specific scheme, effective date, and any share-swap or consideration involved are awaited in the company's detailed filing.

Likely market impact

For shareholders, this order could trigger a restructuring event that may affect shareholding patterns, stock price, or corporate structure, depending on the specifics of the arrangement. Investors should watch for the detailed order and any next steps such as stock exchange filings or shareholder communication.